Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-Hydroxy-1,2,3-propanetricarboxylic acid hydrate (1:1) | HCID 22230 | — |
| Reactant | HCID 131734729 | HCID 131734729 | — |
| Solvent | Water | HCID 962 | — |
| Product | Tofacitinib Citrate | HCID 10174505 | 89% |
Reaction Steps
Water (0.5 mL) was added to amorphous tofacitinib hydrochloride (530 mg, 1.519 mmol). Complete dissolution was observed. A solution of citric acid monohydrate (480 mg, 2.279 mmol) and potassium carbonate (126 mg, 0.911 mmol) in water (10 mL) was added. A white suspension was formed in approximately 1 to 2 minutes. The suspension was stirred at 23 to 25° C. for 12 hours, filtered, washed with water (2×10 mL) and acetone (5 mL). The damp cake was dried under vacuum (5 torr) at 23 to 25° C. for 4 hours to yield tofacitinib citrate (680 mg; 89%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09260438B2 |
|---|
| Source dataset | uspto-grants-2016_02 |
|---|
| ORD ID | ord-08c87d73cc8f4b889675615e9deb92fa |
|---|
| Source note | uspto-grants-2016_02 |
|---|